Gynecological Oncology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium.
Department of Gynecology and Obstetrics; Innsbruck Medical Univeristy, Innsbruck, Austria.
Int J Gynecol Cancer. 2020 Apr;30(4):466-472. doi: 10.1136/ijgc-2019-000961. Epub 2020 Feb 19.
With the expansion of the use of minimally invasive surgical techniques within the field of gynecological oncology, a robot assisted procedure seems to be an attractive technique for para-aortic lymph node sampling. The aim of this study was to compare robotic versus conventional laparoscopic para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
In this monocentric retrospective study, we included patients with locally-advanced cervical cancer (International Federation of Gynecology and Obstetrics (FIGO) 2009 stage IB2-IVA or IB1 with suspicious pelvic lymph nodes), who underwent a para-aortic lymphadenectomy up to the inferior mesenteric artery between December 1994 and December 2016 (robotic technique starting from December 2012).
A total of 217 patients were included in the study (robotic, n=55 vs laparoscopic, n=162). When comparing conventional laparoscopic versus robotic para-aortic lymphadenectomy, the median age was 48 versus 49 years and the median body mass index was 24.4 vs 24.7 kg/m, respectively. In the robotic or laparoscopic group, 85% and 83% were squamous carcinomas, respectively. Patients who underwent a robotic procedure had a higher American Society of Anesthesiologists (ASA) score (ASA2: 62% vs 56%, ASA3: 20% vs 2%, p<0.001), more prior major abdominal surgery (18% vs 6%, p=0.016), less estimated blood loss (median, 25 mL vs 62.5 mL, p<0.001), more para-aortic lymph nodes removed (11 vs 6, p<0.001), shorter postoperative stay (1.8 vs 2.3 days, p=0.002), and a higher, but non-significant, rate of metastatic para-aortic lymph nodes (13% vs 5%, p=0.065) compared with the laparoscopic procedure, respectively. There was no difference in complication rates between the two approaches. The most frequent complications were grade I and grade II according to the Clavien Dindo classification. No difference was observed in progression-free survival between robotic and laparoscopic para-aortic lymphadenectomy after 2 years (both groups 66%) (p=0.472). Also, 2 year overall survival was similar between the groups (77% vs 81% for robotic vs conventional laparoscopy group, respectively) (p=0.749).
Robotic para-aortic lymphadenectomy in patients with locally-advanced cervical cancer resulted in better perioperative outcomes and similar survival outcomes when compared with a conventional laparoscopic approach.
随着妇科肿瘤领域微创技术的应用不断扩大,机器人辅助手术似乎是一种有吸引力的腹主动脉旁淋巴结取样技术。本研究旨在比较机器人辅助与传统腹腔镜腹主动脉旁淋巴结切除术在局部晚期宫颈癌患者中的应用。
这是一项单中心回顾性研究,我们纳入了局部晚期宫颈癌(国际妇产科联合会 2009 年分期为 IB2-IVA 期或 IB1 期伴可疑盆腔淋巴结转移)患者,这些患者在 1994 年 12 月至 2016 年 12 月期间接受了腹主动脉旁淋巴结切除术(机器人技术从 2012 年 12 月开始)。
共有 217 名患者纳入本研究(机器人组 55 例,腹腔镜组 162 例)。与传统腹腔镜腹主动脉旁淋巴结切除术相比,机器人组和腹腔镜组的中位年龄分别为 48 岁和 49 岁,中位体重指数分别为 24.4kg/m 和 24.7kg/m。在机器人组或腹腔镜组中,85%和 83%分别为鳞癌。接受机器人手术的患者美国麻醉医师协会(ASA)评分更高(ASA2:62%比 56%,ASA3:20%比 2%,p<0.001),既往有更多的大型腹部手术史(18%比 6%,p=0.016),估计出血量更少(中位数 25ml 比 62.5ml,p<0.001),切除的腹主动脉旁淋巴结更多(11 枚比 6 枚,p<0.001),术后住院时间更短(1.8 天比 2.3 天,p=0.002),腹主动脉旁淋巴结转移率更高,但无统计学意义(13%比 5%,p=0.065)。与腹腔镜手术相比,机器人手术的并发症发生率无差异。最常见的并发症是根据 Clavien Dindo 分级为 I 级和 II 级。两组患者在 2 年时无进展生存率无差异(两组均为 66%)(p=0.472)。此外,两组患者在 2 年时的总生存率相似(机器人组为 77%,腹腔镜组为 81%)(p=0.749)。
与传统腹腔镜方法相比,机器人辅助腹主动脉旁淋巴结切除术在局部晚期宫颈癌患者中可获得更好的围手术期结果和相似的生存结果。